Patents by Inventor Laurent Bernard Fisher

Laurent Bernard Fisher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Articular cartilage gene therapy with recombinant vector encoding BMP-7
    Patent number: 7846428
    Abstract: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of osteoarthritis in mammals, advantageously in humans, dogs, horses and cats, by intra-articular administration of the recombinant vectors and pharmaceutical compositions of the invention.
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: December 7, 2010
    Assignee: Merial Limited
    Inventor: Laurent Bernard Fisher
  • Gene therapy for renal failure
    Patent number: 7772205
    Abstract: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic renal failure in mammals, advantageously in dogs and cats, by administration of the recombinant vectors and pharmaceutical compositions of the invention.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: August 10, 2010
    Assignee: Merial Limited
    Inventor: Laurent Bernard Fisher
  • Plasmid encoding canine BMP-7
    Patent number: 7598364
    Abstract: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic renal failure in mammals, advantageously in dogs and cats, by administration of the recombinant vectors and pharmaceutical compositions of the invention.
    Type: Grant
    Filed: November 14, 2006
    Date of Patent: October 6, 2009
    Assignee: Merial Limited
    Inventor: Laurent Bernard Fisher
  • Articular Cartilage Gene Therapy with Recombinant Vector Encoding BMP-7
    Publication number: 20090093427
    Abstract: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of osteoarthritis in mammals, advantageously in humans, dogs, horses and cats, by intra-articular administration of the recombinant vectors and pharmaceutical compositions of the invention.
    Type: Application
    Filed: October 5, 2007
    Publication date: April 9, 2009
    Inventor: Laurent Bernard Fisher
  • GENE THERAPY FOR RENAL FAILURE
    Publication number: 20090082301
    Abstract: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic renal failure in mammals, advantageously in dogs and cats, by administration of the recombinant vectors and pharmaceutical compositions of the invention.
    Type: Application
    Filed: November 19, 2008
    Publication date: March 26, 2009
    Inventor: Laurent Bernard Fisher
  • Intra-vascular kidney gene therapy with plasmid encoding BMP-7
    Publication number: 20090082290
    Abstract: The present invention relates to recombinant vectors expressing the BMP-7 polypeptide in host cells and to pharmaceutical compositions comprising such recombinant vectors. The invention also encompasses methods for prevention and/or treatment of both acute and chronic renal failure in mammals, advantageously in humans, dogs and cats, by intra-vascular kidney administration of the recombinant vectors and pharmaceutical compositions of the invention.
    Type: Application
    Filed: May 11, 2007
    Publication date: March 26, 2009
    Inventor: Laurent Bernard Fisher
  • Canine GHRH gene, polypeptides and methods of use
    Patent number: 7468273
    Abstract: The present invention relates to a canine pre-proGHRH polypeptide, a canine mature GHRH peptide, an isolated polynucleotide which encodes the canine pre-proGHRH or the canine mature GHRH. The invention also encompasses vectors encoding and expressing the canine pre-proGHRH or the canine GHRH which can be used to treat disease and growth hormone deficiencies by gene therapy in vertebrates, in particular in dogs.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: December 23, 2008
    Assignee: Meial Limited
    Inventors: Laurent Bernard Fisher, Nathalie Michele Cachet, Simona Barzu-Le-Roux
  • Canine pre-proGHRH and mature GHRH genes
    Patent number: 7351815
    Abstract: The present invention relates to a canine pre-proGHRH polypeptide, a canine mature GHRH peptide, an isolated polynucleotide which encodes the canine pre-proGHRH or the canine mature GHRH. The invention also encompasses vectors encoding and expressing the canine pre-proGHRH or the canine GHRH which can be used to treat disease and growth hormone deficiencies by gene therapy in vertebrates, in particular in dogs.
    Type: Grant
    Filed: May 3, 2004
    Date of Patent: April 1, 2008
    Assignee: Merial Limited
    Inventors: Laurent Bernard Fisher, Nathalie Michele Cachet, Simona Barzu-Le Roux